FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, and concerns the new application of carboxyamidotriazole (CAT) and its analogues. What is offered is using these compounds in preparing formulations for treating TNF-α and/or IL-1β mediated diseases different from a malignant tumour, particularly the diseases associated with pain caused by inflammation, chemical or physical action or injury, as well as bacterial infection. Also, there are presented pharmaceutical compositions containing an effective amount of carboxyamidotriazole (CAT) and its analogues, and an effective amounts of analgesics, or anti-inflammatory analgesics, or anti-inflammatory drugs.
EFFECT: group of inventions provides the extended range of the drugs for treating the TNF-α and/or IL-1β diseases different from a malignant tumour.
6 cl, 9 dwg, 10 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF ARSENIC COMPOUNDS TO TREAT TISSUE OR ORGAN REJECTION | 2013 |
|
RU2665362C2 |
| USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT | 2008 |
|
RU2630574C2 |
| APPLICATION OF TIMOSAPONIN B-II IN MAKING DRUG OR PRODUCT FOR STROKE PREVENTION AND TREATMENT | 2005 |
|
RU2376993C2 |
| USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT | 2008 |
|
RU2468806C2 |
| PHARMACEUTICAL COMPOSITION INHIBITING BONE RESORPTION OR PROMOTING OSTEOGENESIS | 1994 |
|
RU2136275C1 |
| NOVEL EFFICIENT INHIBITOR OF KINASE 4, ASSOCIATED WITH INTERLEUKIN-1 (IRAK4) | 2015 |
|
RU2613973C1 |
| TETRACYCLINE DERIVATIVES | 1994 |
|
RU2138507C1 |
| METHOD OF LYMPHOTROPIC NON-NARCOTIC ANALGESIA OF ONCOLOGICAL PATIENTS | 2019 |
|
RU2720108C1 |
| PYRIMIDINE INDOLE COMPOUNDS | 2010 |
|
RU2552999C2 |
| METHODS AND COMPOSITIONS FOR AUTOIMMUNE AND INFLAMMATORY DISEASES TREATMENT | 2012 |
|
RU2639540C2 |
